Outcomes Following Discontinuation of Warfarin in Heartmate 3 Patients: A Multi-Center Review

Bleeding complications during left ventricular assist device (LVAD) support pose anticoagulation challenges as risk of discontinuation of anticoagulation, even in the setting of bleeding, may pose an increased risk of subsequent LVAD hemolysis or thrombosis. We assessed whether discontinuation of anticoagulation in HM3 patients whose bleeding concerns preventing anticoagulation would adversely impact outcomes.

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: S. Schettle, J. Stulak, A. Rosenbaum, C. Cheyne, B. Ayers, J. Alexis, I. Gosev Tags: (999) Source Type: research